Biosynex SABiosynex SABiosynex SA

Biosynex SA

No trades
Market capitalization
‪16.19 M‬EUR
−4.312EUR
‪−43.33 M‬EUR
‪101.17 M‬EUR
‪7.90 M‬
Beta (1Y)
0.21
Employees (FY)
486
Change (1Y)
−89 −15.48%
Revenue / Employee (1Y)
‪208.16 K‬EUR
Net income / Employee (1Y)
‪−89.16 K‬EUR

About Biosynex SA


CEO
Larry Abensur
Headquarters
Illkirch-Graffenstaden
Founded
2005
IPO date
Mar 21, 2011
Identifiers
2
ISIN FR0011005933
Biosynex SA engages in the provision of development, production, and distribution of Rapid Diagnostics Tests (RDTs) for pathologies. It operates through the Professional and Consumer segments. The Professional segment allows proper medical management of the patients. The Consumer segment permits the general public to self-monitor. The company was founded by Larry Abensur, Thomas Lamy, and Thierry Paper on March 15, 2005 and is headquartered in Illkirch-Graffenstaden, France.

Check out other big names from the same industry as ALBIO.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently asked questions


The current price of ALBIO is 0.864 EUR — it has decreased by −1.12% in the past 24 hours. Watch Biosynex SA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange Biosynex SA stocks are traded under the ticker ALBIO.
ALBIO stock has fallen by −5.58% compared to the previous week, the month change is a −8.33% fall, over the last year Biosynex SA has showed a −48.82% decrease.
ALBIO reached its all-time high on Apr 15, 2021 with the price of 25.088 EUR, and its all-time low was 0.456 EUR and was reached on Dec 2, 2025. View more price dynamics on ALBIO chart.
See other stocks reaching their highest and lowest prices.
ALBIO stock is 3.49% volatile and has beta coefficient of 0.21. Track Biosynex SA stock price on the chart and check out the list of the most volatile stocks — is Biosynex SA there?
Today Biosynex SA has the market capitalization of ‪15.83 M‬, it has decreased by −7.45% over the last week.
Yes, you can track Biosynex SA financials in yearly and quarterly reports right on TradingView.
ALBIO net income for the last half-year is ‪−48.60 M‬ EUR, while the previous report showed ‪−22.41 M‬ EUR of net income which accounts for 0.00% change. Track more Biosynex SA financial stats to get the full picture.
As of Mar 10, 2026, the company has 486 employees. See our rating of the largest employees — is Biosynex SA on this list?
Like other stocks, ALBIO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Biosynex SA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Biosynex SA technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Biosynex SA stock shows the sell signal. See more of Biosynex SA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.